The Latin America, Middle East and Africa Facial Aesthetics Market is expected to witness market growth of 17.1% CAGR during the forecast period (2022-2028).
When carried out by certified professionals, facial cosmetic treatments are completely safe. Additionally, there is little to no downtime needed during treatment, allowing patients to continue their normal activities right away. The ability to consistently recommend facial injectables, including Botox and dermal fillers, to patients allows renowned beauty and skin care clinics, dermatology clinics, and restorative experts to operate.
Topical neurotoxins could replace injectable medicines (such as Dysport and Botox Cosmetic) as patients shift more and more toward minimally invasive procedures. Botox and dermal face filler injections, laser therapy, dental implantation, facial contouring, and micro-dermabrasions are among the treatments or therapies used in facial aesthetics. Due to the fact that fashionable procedures are optional and just restorative, the market for facial aesthetics is particularly vulnerable to financial turmoil.
In the United Arab Emirates, there has been an upsurge in the use of cosmetic surgery during the last ten years. The average age of those who undergo cosmetic operations is under 35 for about one-third of patients. The United Arab Emirates (UAE) is now a center for cosmetic surgery in the LAMEA region. Through surgical and therapeutic interventions, cosmetic operations aim to preserve, rejuvenate, or improve physical appearance. In the UEA, there has been a sharp increase in the number of cosmetic treatments performed just in the last ten years.
The Brazil market dominated the LAMEA Facial Aesthetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $262.9 million by 2028. The Argentina market is experiencing a CAGR of 17.7% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 16.8% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
When carried out by certified professionals, facial cosmetic treatments are completely safe. Additionally, there is little to no downtime needed during treatment, allowing patients to continue their normal activities right away. The ability to consistently recommend facial injectables, including Botox and dermal fillers, to patients allows renowned beauty and skin care clinics, dermatology clinics, and restorative experts to operate.
Topical neurotoxins could replace injectable medicines (such as Dysport and Botox Cosmetic) as patients shift more and more toward minimally invasive procedures. Botox and dermal face filler injections, laser therapy, dental implantation, facial contouring, and micro-dermabrasions are among the treatments or therapies used in facial aesthetics. Due to the fact that fashionable procedures are optional and just restorative, the market for facial aesthetics is particularly vulnerable to financial turmoil.
In the United Arab Emirates, there has been an upsurge in the use of cosmetic surgery during the last ten years. The average age of those who undergo cosmetic operations is under 35 for about one-third of patients. The United Arab Emirates (UAE) is now a center for cosmetic surgery in the LAMEA region. Through surgical and therapeutic interventions, cosmetic operations aim to preserve, rejuvenate, or improve physical appearance. In the UEA, there has been a sharp increase in the number of cosmetic treatments performed just in the last ten years.
The Brazil market dominated the LAMEA Facial Aesthetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $262.9 million by 2028. The Argentina market is experiencing a CAGR of 17.7% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 16.8% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
Scope of the Study
Market Segments Covered in the Report:
By Product- Dermal fillers
- Botulinum toxin
- Microdermabrasion
- Chemical peels
- Others
- Facial line correction treatment
- Scar treatment
- Lip enhancement
- Restoration of volume or Fullness
- Others
- Hospitals
- Specialty & Dermatology Clinics
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Facial Aesthetics Market by Product
Chapter 5. LAMEA Facial Aesthetics Market by Application
Chapter 6. LAMEA Facial Aesthetics Market by End User
Chapter 7. LAMEA Facial Aesthetics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
Methodology
LOADING...
